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Background: Hot tub lung is an emerging lung disorder associated with exposure to
Mycobacterium avium complex organisms contaminating hot tub water.
Objectives: To define the clinical characteristics and outcome of patients with hot
tub lung.
Methods: Retrospective review of 21 patients diagnosed with hot tub lung at a
tertiary medical center over a 7-year period.
Results: The mean (7SD) age at presentation was 46 (7 15) years; 9 patients were
men (43%). All patients described ongoing exposure to hot tubs. The most common
referral diagnoses were sarcoidosis, bronchitis, and asthma. Dyspnea and cough
were present in all patients, hypoxemia was noted in 10 patients (48%). High-
resolution computed tomography of the chest had been performed in 20 patients and
demonstrated diffuse centrilobular nodules and/or ground-glass opacities in all
patients. M. avium complex was isolated from the hot tub water, respiratory
secretions and/or lung tissue in all patients. Bronchoscopic or surgical lung biopsy
was obtained in 18 patients and demonstrated bronchiolocentric granulomatous
inflammation. With avoidance of exposure, clinical and radiologic improvement was
observed in all patients. Additionally, 13 patients (62%) received corticosteroid
therapy, 1 (5%) antimycobacterial therapy, 2 (10%) received both, and 5 patients
(24%) received no pharmacologic therapy.
Conclusions: Hot tub lung likely represents hypersensitivity pneumonitis due to
inhalational exposure to M. avium complex. Antimycobacterial therapy does not
appear to be required in the management of this disease. Although corticosteroidsElsevier Ltd. All rights reserved.
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Hot tub lung 611may be helpful in the treatment of severely affected patients, others can be
managed by avoidance of additional exposure alone.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Hot tub lung is an emerging disorder caused by
exposure to Mycobacterium avium complex (MAC)
organisms contaminating hot tub water. The de-
scription of this disorder has been limited to several
case reports published since 1997.1–9 Patients
described in these reports have been treated with
antimycobacterial drugs and/or corticosteroids
although some patients appeared to improve with
hot tub avoidance alone.7,8 There is a continuing
debate on optimal management of these patients
and whether the antimycobacterial therapy is
required. In this study, we sought to better
characterize the presenting features, clinical
course and treatment of this illness by identifying
and reassessing a cohort of patients who met a
proposed set of diagnostic criteria. Our results
suggest that hot tub lung is more likely a form of
hypersensitivity pneumonitis rather than a myco-
bacterial infection and that treatment with anti-
mycobacterial drugs is likely unnecessary.Table 1 Epidemiologic and clinical features for
21 patients with hot tub lung.
Characteristics No. (%)
Male 9 (43)
Age, years 46715
Smoking history
Previous 7 (33)
Current 1 (5)Methods
Patient selection
A computer-assisted search was conducted to
identify all cases of hot tub lung seen at the Mayo
Clinic, Rochester, MN between April 1, 1997 and
March 31, 2004. Electronic medical records were
searched for phrases related to ‘‘Mycobacterium
avium complex’’ and ‘‘hot tub lung’’. The study was
approved by the Mayo Foundation Institutional
Review Board.Never 13 (62)
Presenting symptoms
Cough 21 (100)
Dyspnea 21 (100)
Fever 13 (62)
Chest tightness 10 (48)
Weight loss 4 (19)
Physical findings
Crackles 11 (52)
Wheezing 1 (5)
Digital clubbing 0 (0)
Expressed as mean 7SD.Diagnostic criteria
We identified 21 patients who fulfilled our diag-
nostic criteria for hot tub lung including: (1)
persistent respiratory symptoms, (2) diffuse lung
infiltrates on chest radiography or computed
tomography, (3) exposure to hot tub prior to the
onset of illness, (4) MAC isolated from respiratory
secretion, hot tub water sample or lung tissue
biopsy, and (5) no other identifiable cause for the
illness. Ten of these 21 patients were included in
previous publications from this institution.7,8Clinical data and laboratory results
Clinical data and test results were abstracted from
the medical records. Clinical outcome was assessed
at the time of the last available follow-up. High-
resolution computed tomography (HRCT) images
and lung biopsy specimens were evaluated by an
expert thoracic radiologist (TEH) and lung pathol-
ogist (HDT), respectively. Pulmonary function was
measured by standard techniques and obstructive,
restrictive, and nonspecific patterns were defined
by previously described criteria.10 Arterial hypox-
emia was defined as PaO2p55mmHg or SaO2p88%
on room air. The presence of MAC in the micro-
biologic specimens was confirmed by DNA probe
(AccuProbe, Gen-Probe Inc., San Diego, CA).Results
Clinical features
Demographic data and presenting clinical features
of 21 patients are summarized in Table 1. The mean
(7SD) age at presentation was 46 (715) years; 9
were men (43%). The duration of exposure to the hot
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Figure 1 High-resolution computed tomography of the
chest revealing patchy areas of ground-glass attenuation
and ill-defined centrilobular nodules scattered in both
lungs (A) with air trapping on expiration (B) in a 27-year-
old man with hot tub lung.
V. Hanak et al.612tub prior to symptom onset was highly variable
ranging from 2 months to 17 years (median, 26
months). All patients described ongoing exposure to
hot tubs. The median duration of symptoms prior to
diagnosis was 5 months (range, 1–54 months). All
patients noted dyspnea and cough at presentation.
Low-grade fever, chest tightness, unintentional
weight loss, and other nonspecific systemic symp-
toms were less commonly present. Initial symptom
onset had the character of an acute flu-like illness in
13 patients (62%). Only 4 patients (19%) described a
temporal relationship between episodes of hot tub
use and exacerbation of symptoms. In fact, several
patients had increased their hot tub use in an effort
to alleviate the persistent symptoms of their illness.
Prior to the referral to our medical center 20
patients had been rendered other diagnoses includ-
ing sarcoidosis (6 patients), bronchitis (6 patients),
asthma (3 patients), MAC infection (1 patient),
bronchiolitis obliterans (1 patient), eosinophilic
bronchiolitis (1 patient), farmer’s lung (1 patient),
and mycotoxicosis (1 patient). Although MAC had
been recovered from respiratory secretions in
several patients, these isolates were usually re-
garded as colonization.
Chest radiographs were available in 18 patients
and revealed diffuse interstitial or nodular infiltrates
in 14 (78%), but were normal in 4 patients (22%)
(Table 2). HRCT of the chest had been performed in
20 patients and were abnormal in all cases. Diffuse
centrilobular micro-nodules and/or ground-glass
opacities were seen in all cases (Fig. 1).
Pulmonary function testing was performed in all
patients at the time of the initial visit to our
medical center (Table 3) and was abnormal in 19
patients (90%). An obstructive pattern was seen in 6
(29%) and a restrictive pattern in 4 patients (19%).
An isolated reduction in diffusing capacity for
carbon monoxide was found in 4 patients (19%)
and a nonspecific pattern of abnormality was noted
in 5 patients (24%). The remaining 2 patients hadTable 2 Radiologic findings at presentation.
Characteristics No. (%)
Chest radiography (n ¼ 18)
Diffuse nodular or interstitial infiltrates 14 (78)
Normal 4 (22)
High-resolution CT (n ¼ 20)
Diffuse centrilobular micronodules 13 (65)
Diffuse ground-glass opacities 13 (65)
Air trapping on expiratory views 11 (100)
CT, computer tomography.
Expiratory views were performed on 11 patients.normal pulmonary function results. Arterial hypox-
emia was present in 10 patients (48%).
Mycobacterial culture (Table 3) revealed the
presence of MAC in 89% of the tested hot tub water
samples (17 out of 19), in 75% sputum samples (9
out of 12), in 44% bronchioalveolar lavage samples
(4 out of 9) and 75% lung tissue samples (6 out of 8).
Serum angiotensin-converting enzyme level was
abnormally elevated in 3 of 8 patients (38%) tested.
Bronchoalveolar lavage fluid was analyzed for cell
content in 5 patients and showed marked lympho-
cytosis (5874%, mean7SD) in all 5 patients with a
median CD4:CD8 lymphocyte ratio of 10 (range,
4–97).
Lung biopsies were performed in 18 patients and
yielded 21 specimens: 10 patients underwent
transbronchial lung biopsy alone, 5 surgical biopsy
alone, and 3 underwent both procedures. Acid-fast
stains were positive in 2 of 17 lung tissue specimens
(12%). Bronchiolocentric granulomatous inflamma-
tion was present in 11 transbronchial (85%) and 8
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Table 3 The results of pulmonary function testing, the lung tissue sampling, the microbiology results and the
treatment outcome in 21 patients with hot tub lung.
No. Pulmonary function Tissue biopsy Culture results Treatment results
FVC FEV1 DLCO TBBx SBx Stain Sputum Tissue Lavage Water ATB Steroid Outcome

1 59 58 65 G  + + + + R
2 54 45 68 G  + + I
3 70 58 72 + + R
4 81 88 84 G  +  + R
5 79 72 60 G  + + + R
6 105 89 65 G  + + I
7 37 30 52 G + + + + + I
8 83 69 100  + + R
9 44 39 55 G     + + R
10 61 67 39 G  + + R
11 53 40 55 G   + + I
12 55 54 81 NC G  + + + I
13 108 106 42 G  + +  + R
14 51 55 37 G + + +  + + I
15 73 48 76 G   + + I
16 93 88 62 G  +  + + + I
17 93 48 77 G G + + + + R
18 70 68 63 NC G  + + I
19 72 62 91 G   + + R
20 92 93 66 + R
21 89 95 72 G   + + I
Blank spaces indicate ‘‘not done’’ or ‘‘not applicable’’.
FVC, forced vital capacity; FEV1, forced expiratory volume in 1 s; DLCO, diffusing capacity for carbon monoxide; TBBx,
transbronchial lung biopsy; SBx, surgical lung biopsy; G, granulomas; NC, noncontributory result; lavage, bronchioalveolar
lavage; water, hot tub water; ATB, antimycobacterials; steroids, corticosteroids; outcome R, resolved; outcome I, improved.
Pulmonary function tests expressed as % predicted.
Median duration of follow-up was 5 months (range, 1–73 months).
Figure 2 Photomicrograph of right lower lung transbron-
chial biopsy (100 , H&E stain) revealing well-formed
non-necrotizing granulomas and a mild chronic inter-
stitial pneumonia.
Hot tub lung 613surgical (100%) lung biopsies (Table 3). The granu-
lomas were well formed, and predominantly non-
necrotizing. They tended to be multiple, werefrequently adjacent to airways, in bronchiolar walls
or within bronchiolar lumens, but were just as
often randomly distributed within airspaces, and
the interstitium (Fig. 2). Organizing pneumonia
with airspace-filling fibroblastic plugs and alveolar
septal thickening due to a chronic inflammatory
cell infiltrate were common. Pleural and septal
involvement (characteristic of sarcoid granulomas)
were not present.Treatment and clinical outcome
At the time of their initial presentation to our
medical center, the majority of patients had been
treated for bronchitis or pneumonia with empiric
antibiotic therapy as well as bronchodilators. Over
one-half of the patients had been given a trial of
corticosteroid therapy that was combined with
antimycobacterial therapy in 3 patients. After
establishing the diagnosis of hot tub lung, all
patients were advised to avoid further exposure
to a hot tub. In addition, 13 patients were treated
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ial agents alone, and 2 with a combined corticos-
teroid and antimycobacterial treatment regimen
(Table 3). Median duration of follow-up was 5
months (range, 1–73 months). Improvement was
documented in all patients, including complete
resolution of symptoms and radiographic abnorm-
alities in 11 patients (52%) at the time of the last
follow-up. There were no cases of clinical dete-
rioration or death.Discussion
Hot tub lung represents a recently recognized form
of MAC-associated lung disease.1–9 Patients with
hot tub lung described in this study were all
immunocompetent with no preexisting lung dis-
ease. The clinical picture was commonly character-
ized by an acute flu-like illness followed by
protracted respiratory symptoms related to recur-
ring hot tub exposure. Aside from the exposure
history, the most helpful clues to the diagnosis
were typical HRCT findings of diffuse micronodular
and/or ground glass opacities, histopathologic
changes of bronchiolocentric granulomatous in-
flammation on a lung biopsy, and microbiologic
identification of MAC in the hot tub water or
respiratory specimen. Sarcoidosis was a common
referral diagnosis, likely related to the well (rather
than loosely)-formed granulomas on histopathol-
ogy, high CD4:CD8 lymphocyte ratio in bronchoal-
veolar lavage fluid, elevated serum angiotensin-
converting enzyme levels, and apparent response
to corticosteroid therapy. Although the identifica-
tion of MAC in the hot tub water may be helpful in
the diagnosis of hot tub lung, it should be noted
that the prevalence of MAC in hot tubs overall is not
known. No other single organism, including fungal
species, has been consistently isolated from both
patient and hot tub water in these cases of hot tub-
related interstitial lung disease.
There is a continued debate as to whether hot
tub lung represents an infectious or hypersensitiv-
ity phenomenon related to MAC organisms.8 Patho-
genic potential of MAC is well known, particularly
in immunocompromised hosts. In addition, some
histopathologic features such as areas of necrosis
that are sometimes seen in the granulomatous
inflammation may suggest an infection. However,
immunocompetent status of these patients, HRCT
features, spontaneous improvement with cessation
of hot tub exposure, and improvement (rather than
worsening) with corticosteroid therapy strongly
argue for hot tub lung representing a hypersensi-tivity pneumonitis related to repeated MAC ex-
posure. Mycobacteria have been known to cause
hypersensitivity reactions related to the antigenic
components of their acid-rich cell wall.11,12 Inhaled
muramyl dipeptide, an important antigenic compo-
nent of mycobacterial wall, has been used as an
adjuvant in animal models to produce chronic
hypersensitivity pneumonitis.11 Systemic hypersen-
sitivity reaction including granulomatous hepatitis
and pneumonitis has been seen as a complication of
bladder cancer treatment using intravesical instil-
lation of bacillus Calmette–Guerin and resolves
rapidly with corticosteroid therapy.12
It is interesting that patients in our study often did
not associate episodes of hot tube use with exacerba-
tion of symptoms. In fact, patients typically continued
or even increased their hot tub use after the onset of
their symptomatic illness in an attempt to ameliorate
their respiratory symptoms with humidified air. Episo-
dic nature of symptoms is commonly observed in acute
hypersensitivity pneumonitis but is often absent in
subacute and chronic cases.13
The uncertainty about the pathogenesis of hot
tub lung has caused confusion regarding appro-
priate management of these patients as seen in our
series of cases. Specifically, it has been unclear
whether antimycobacterial therapy is required in
the treatment of patients with hot tub lung.
Clearly, our results suggest that antimycobacterial
therapy is not a necessary component in the
management of most patients with this illness.
Most of our patients were managed with avoidance
of further exposure to hot tub with or without
corticosteroid therapy. Improvement was seen in
all of our patients although nearly one-half had
severe lung dysfunction resulting in hypoxemia.
This clinical course contrasts sharply with that of
pulmonary infection with MAC which typically
requires a multi-drug regimen of antimycobacterial
agents given for a prolonged duration of more than
a year.
Given the widespread use of hot tubs, it is
important for the general public and clinicians to
be aware of the hot tub lung and other health
hazards associated with their use.14–16 All of our
patients had indoor hot tubs. It is possible that the
aerosolization and inhalation of contaminated hot
tub water in an enclosed space augmented the
antigen exposure to these susceptible hosts. The
confined space and aerosolization seems to be
important and may contribute to greater inhala-
tional exposure possibly even with a use of regular
shower, as suggested by recently published isolated
case report.17 The prevalence of MAC contamina-
tion in hot tubs overall is unknown. Given the
ubiquitous nature of MAC organisms and their
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sources, it is possible that contamination of hot
tubs is rather prevalent and that this disease is
under-reported. It is also possible that poor
compliance with hot tub maintenance may be
playing a role the proliferation of MAC in the hot
tub water. In our patients, the lack of adherence to
proper hot tub maintenance appeared to be not
uncommon.
There was significant variation in the severity
and temporal course of the disease between
patients. This likely reflects multiple variables
including problems with timing the first exposure
as well as quantifying subsequent frequency of use,
the difficulty in establishing when a hot tub
becomes colonized by MAC and when exposure
levels reach a critical disease-producing threshold,
the impact of various treatments and other poorly
defined host factors. All of these would predict a
heterogeneous clinical presentation which makes a
high degree of clinical suspicion an important
factor in the accurate recognition of this disease.
In conclusion, hot tub lung is a respiratory illness
caused by recurring exposure to MAC and is
associated with characteristic HRCT and histo-
pathologic features. This disease likely represents
a hypersensitivity pneumonitis rather than an
infection. Antimycobacterial therapy does not
appear to be required in the management of most
patients with this disorder. Corticosteroid therapy
may be helpful in the management of severely
affected patients although recovery is often
achieved by simply avoiding further exposure.
Given the prevalent use of hot tubs, inquiry
regarding hot tub exposure should be included in
the interview of all patients with suspected
interstitial lung disease.References
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